Bausch Health Companies (BHC) Stock Price, News & Analysis

Company Overview

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.

Key Stats

• Today's Range: C$7.58 to C$7.81
• 50-Day Range: C$6.82 to C$8.37
• 52-Week Range: C$6.06 to C$11.97
• Volume: 399,528 shs
• Average Volume: 466,609 shs
• Market Capitalization: C$2.88 billion
• P/E Ratio: N/A
• Dividend Yield: 0.76%
• Price Target: N/A
• Consensus Rating: Hold

Bausch Health Companies Stock Analysis - MarketRank™

Bausch Health Companies scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Bausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Bausch Health Companies has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Bausch Health Companies is -2.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Bausch Health Companies is -2.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Bausch Health Companies has a PEG Ratio of 0.21. PEG Ratios below 1 indicate that a company could be undervalued.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for BHC.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Bausch Health Companies has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Bausch Health Companies does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.22

News Sentiment

Bausch Health Companies has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Bausch Health Companies this week, compared to 1 article on an average week.

Search Interest

Only 6 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Bausch Health Companies insiders have not sold or bought any company stock.

Percentage Held by Insiders

11.28% of the stock of Bausch Health Companies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

13.47% of the stock of Bausch Health Companies is held by institutions.

BHC Stock Analysis - Frequently Asked Questions

How have BHC shares performed this year?

Bausch Health Companies' stock was trading at C$9.53 at the beginning of 2026. Since then, BHC shares have decreased by 19.2% and is now trading at C$7.70.

How were Bausch Health Companies' earnings last quarter?

Bausch Health Companies Inc. (TSE:BHC) announced its earnings results on Wednesday, April, 29th. The company reported $1.08 EPS for the quarter. The firm earned $3.51 billion during the quarter. Bausch Health Companies had a negative net margin of 13.54% and a positive trailing twelve-month return on equity of 120.43%.

How do I buy shares of Bausch Health Companies?

Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Meta Platforms (META), Advanced Micro Devices (AMD), Enbridge (ENB), Shopify (SHOP), NVIDIA (NVDA) and Ford Motor (F).

Company Calendar

• Last Earnings: 4/29/2026
• Today: 5/05/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:BHC
• CIK: N/A
• Web: www.valeant.com
• Phone: 514-744-6792
• Fax: N/A
• Employees: 19,900
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($3.24)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 1.39
• P/E Growth: 0.21
• Net Income: -C$125.65 million
• Net Margins: -13.54%
• Pretax Margin: N/A
• Return on Equity: 120.43%
• Return on Assets: 4.16%

Debt

• Debt-to-Equity Ratio: -1,009.96
• Current Ratio: 1.32
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: C$10.53 billion
• Price / Sales: 0.27
• Cash Flow: C$0.99 per share
• Price / Cash Flow: 7.76
• Book Value: C($2.92) per share
• Price / Book: -2.64

Miscellaneous

• Outstanding Shares: 373,476,000
• Free Float: N/A
• Market Cap: C$2.88 billion
• Optionable: Not Optionable
• Beta: 0.59